FRAMINGHAM HEART STUDY TASK ORDER 1 - BASE PERIOD

弗雷明汉心脏研究任务顺序 1 - 基础期

• 批准号: 10819409
• 负责人: VASAN RAMACHANDRAN
• 金额: $ 482.41万
• 依托单位: BOSTON UNIVERSITY MEDICAL CAMPUS
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-04-01 至 2024-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10819409
• 关键词: Aging; Ancillary Study; Biological Specimen Banks; Clinical; Communities; Data; Disease; Disease Progression; Event; Framingham Heart Study; Functional disorder; Goals; Heart Diseases; Hematological Disease; Knowledge; Lung diseases; Participant; Research Personnel; Resources; Risk Factors; Sleep Disorders; base; clinical examination; clinical predictors; data repository; follow-up; health determinants; progression risk

This renewal is to continue the Framingham Heast Study (FHS) as a scientific resource for the research community to expand knowledge about the determinants of health and disease in heart, lung, blood, and sleep disorders. The overall goals of this acquisition are to (1) enhance statistical power to perform analyses of predictors of clinical events; (2) study the progression of risk factors with aging; and (3) identify new risk factors or interactions between risk factors that inform disease pathophysiology and/or disease progression.

此次更新是为了继续将弗雷明汉希斯特研究 (FHS) 作为研究界的科学资源，以扩大有关心脏、肺、血液和睡眠障碍等健康和疾病决定因素的知识。此次收购的总体目标是（1）增强统计能力以对临床事件的预测因素进行分析； (2)研究危险因素随衰老的进展； (3) 确定新的风险因素或风险因素之间的相互作用，以告知疾病病理生理学和/或疾病进展。